Sep 17, 2026
Hospitals and clinics continue to face a central challenge:
extensive cardiac testing still fails to deliver clear, consistent
diagnostic answers, slowing decision‑making and creating downstream
operational and financial strain.
In this episode, Jim Hartman, Chief Commercial Officer at
Cleerly, examines with host Marilie Fouché how AI‑driven coronary
CTA analysis strengthens diagnostic certainty, streamlines
workflows across radiology, cardiology, and the cath lab, and
supports more defensible adoption decisions for clinical and
operational leaders.
The discussion highlights practical evaluation criteria —
clinical impact, workflow efficiency, and financial return — that
executives can use to assess whether advanced imaging technologies
can be integrated and scaled within their organizations.
This episode is sponsored by Cleerly.
Learn how to identify AI trends by tracking where venture
funding is flowing, and by listening to how leading CEOs describe
risk and competitive strategy, download our free PDF report, "3
Ways to Discover AI Trends in Any Sector" at emerj.com/ait1